NO972702L - Erythromycin A 9-0-oksimderivater som besitter antibiotisk aktivitet - Google Patents

Erythromycin A 9-0-oksimderivater som besitter antibiotisk aktivitet

Info

Publication number
NO972702L
NO972702L NO972702A NO972702A NO972702L NO 972702 L NO972702 L NO 972702L NO 972702 A NO972702 A NO 972702A NO 972702 A NO972702 A NO 972702A NO 972702 L NO972702 L NO 972702L
Authority
NO
Norway
Prior art keywords
erythromycin
antibiotic activity
oxime derivatives
derivatives possessing
possessing antibiotic
Prior art date
Application number
NO972702A
Other languages
English (en)
Other versions
NO972702D0 (no
NO309816B1 (no
Inventor
Franco Pellacini
Giovanna Schioppacassi
Enrico Albini
Daniela Botta
Stefano Romagnano
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of NO972702D0 publication Critical patent/NO972702D0/no
Publication of NO972702L publication Critical patent/NO972702L/no
Publication of NO309816B1 publication Critical patent/NO309816B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO972702A 1994-12-13 1997-06-12 Erytromycin A 9-0-oksimderivater som utviser antibiotisk aktivitet, og farmasøytisk preparat inneholdende disse NO309816B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002496A IT1276901B1 (it) 1994-12-13 1994-12-13 Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
PCT/EP1995/004815 WO1996018633A1 (en) 1994-12-13 1995-12-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Publications (3)

Publication Number Publication Date
NO972702D0 NO972702D0 (no) 1997-06-12
NO972702L true NO972702L (no) 1997-08-13
NO309816B1 NO309816B1 (no) 2001-04-02

Family

ID=11369979

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972702A NO309816B1 (no) 1994-12-13 1997-06-12 Erytromycin A 9-0-oksimderivater som utviser antibiotisk aktivitet, og farmasøytisk preparat inneholdende disse

Country Status (35)

Country Link
US (1) US5847092A (no)
EP (1) EP0797579B1 (no)
JP (1) JPH10510520A (no)
KR (1) KR100367559B1 (no)
CN (1) CN1046535C (no)
AP (1) AP739A (no)
AT (1) ATE190620T1 (no)
AU (1) AU690791B2 (no)
BG (1) BG63261B1 (no)
BR (1) BR9510015A (no)
CA (1) CA2207029A1 (no)
CZ (1) CZ289943B6 (no)
DE (1) DE69515694T2 (no)
DK (1) DK0797579T3 (no)
EE (1) EE03401B1 (no)
ES (1) ES2144154T3 (no)
FI (1) FI972493A7 (no)
GE (1) GEP20012391B (no)
GR (1) GR3033622T3 (no)
HU (1) HU220631B1 (no)
IT (1) IT1276901B1 (no)
LT (1) LT4276B (no)
LV (1) LV11898B (no)
MD (1) MD1788G2 (no)
NO (1) NO309816B1 (no)
NZ (1) NZ297446A (no)
OA (1) OA10491A (no)
PL (1) PL182053B1 (no)
PT (1) PT797579E (no)
RO (1) RO116282B1 (no)
RU (1) RU2152951C1 (no)
SI (1) SI9520124A (no)
TJ (1) TJ306B (no)
UA (1) UA48958C2 (no)
WO (1) WO1996018633A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290447B1 (it) * 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
IT1301967B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivato di eritromicina ad attivita' antibiotica
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6638908B1 (en) 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
RU2186389C1 (ru) * 2001-01-09 2002-07-27 Государственное федеральное учреждение науки Уральский научно-исследовательский институт травматологии и ортопедии Способ культивирования h. influenzae из носоглоточной слизи (варианты)
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
RU2207120C1 (ru) * 2001-12-29 2003-06-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство брилид антибиотического действия
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
RU2240112C1 (ru) * 2003-06-09 2004-11-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая бактериостатическим действием, и способ ее изготовления
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
AU1204288A (en) 1987-02-24 1988-08-25 Beecham Group Plc Erythromycins
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives

Also Published As

Publication number Publication date
BG63261B1 (bg) 2001-07-31
FI972493A0 (fi) 1997-06-12
BG101570A (bg) 1998-02-27
RU2152951C1 (ru) 2000-07-20
DK0797579T3 (da) 2000-06-05
NO972702D0 (no) 1997-06-12
IT1276901B1 (it) 1997-11-03
HUT77126A (hu) 1998-03-02
MX9704253A (es) 1997-09-30
FI972493L (fi) 1997-06-12
KR100367559B1 (ko) 2003-04-21
JPH10510520A (ja) 1998-10-13
DE69515694D1 (de) 2000-04-20
EE03401B1 (et) 2001-04-16
OA10491A (en) 2002-04-10
TJ306B (en) 2001-08-06
EP0797579B1 (en) 2000-03-15
AP9700989A0 (en) 1997-07-31
CZ178697A3 (en) 1997-12-17
WO1996018633A1 (en) 1996-06-20
GEP20012391B (en) 2001-03-25
RO116282B1 (ro) 2000-12-29
LT4276B (lt) 1998-01-26
ATE190620T1 (de) 2000-04-15
FI972493A7 (fi) 1997-06-12
AU690791B2 (en) 1998-04-30
SI9520124A (sl) 1998-04-30
PT797579E (pt) 2000-08-31
PL182053B1 (pl) 2001-10-31
NO309816B1 (no) 2001-04-02
LV11898B (en) 1998-03-20
DE69515694T2 (de) 2000-10-26
GR3033622T3 (en) 2000-10-31
LV11898A (lv) 1997-12-20
US5847092A (en) 1998-12-08
MD1788F2 (en) 2001-11-30
MD1788G2 (ro) 2002-05-31
MD970243A (en) 1999-05-31
CN1046535C (zh) 1999-11-17
UA48958C2 (uk) 2002-09-16
CZ289943B6 (cs) 2002-04-17
CA2207029A1 (en) 1996-06-20
HU220631B1 (hu) 2002-03-28
CN1169727A (zh) 1998-01-07
EE9700124A (et) 1997-12-15
ES2144154T3 (es) 2000-06-01
PL320688A1 (en) 1997-10-27
BR9510015A (pt) 1997-10-28
EP0797579A1 (en) 1997-10-01
ITMI942496A1 (it) 1996-06-13
NZ297446A (en) 1999-06-29
LT97116A (en) 1997-10-27
ITMI942496A0 (it) 1994-12-13
AP739A (en) 1999-03-24
AU4260396A (en) 1996-07-03

Similar Documents

Publication Publication Date Title
FI20050512L (fi) Glykopeptidiantibioottijohdannaisia
NO993876D0 (no) 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater
FI935298L (fi) Anvaendning av rapamycin prolaekemedel som immunosuppressiva medel
FI962751A7 (fi) Uusia hydroksyyliryhmän sisältäviä 1,3-dialkyyliureajohdannaisia
DE69610057D1 (de) Nicht kreisförmige Druckkopföffnung
NO972702L (no) Erythromycin A 9-0-oksimderivater som besitter antibiotisk aktivitet
IL129946A0 (en) Erythromycin a derivatives
PL339575A1 (en) 3'-n-modified, 6-o-substituted ketolydic derivatives of erythromycin exhibiting antibacterial activity
AU6421398A (en) Erythromycin a derivatives
AU9646098A (en) Erythromycin a derivatives
AU2891789A (en) New antibiotic macrolide compounds
AU4472897A (en) Erythromycin a derivatives
AU3121095A (en) Antibiotic macrolides
AU4222797A (en) Erythromycin a derivatives
AR002843A1 (es) Formulaciones de antibioticos ionóforos
AU4472797A (en) Erythromycin a derivatives
AU6921298A (en) Erythromycin a oxime dihydrate
AU4472697A (en) Erythromycin a derivatives
FI943676A7 (fi) Oksiimijohdannaiset, joilla on kefalosporaanirakenne ja yhdisteet niiden valmistamiseksi
FI1630U1 (fi) Utrustningen som laettar fordons inkoerning till garage
SI1100806T1 (en) Erythromycin derivative with antibiotic activity
ITMI932069A1 (it) Nuovo antibiotico
HK1028248A (en) Erythromycin a oxime solvates
NO943547D0 (no) N-t-butyl-androst-3,5-dien-17 , polymorf A
ZA951845B (en) Acid-stabile erythromycin derivatives